Our skilled scientists develop tailored methods to streamline the clinical development phase, enabling diverse PK/PD and clinical studies across multiple biological matrices, biomarkers, and metabolites. With expertise in plasma, serum, blood, CSF, urine, and more, we provide comprehensive support in method development, validation, analysis, and interpretation, adhering to regulatory guidelines. Performing in vitro non-clinical studies alongside clinical trials, our dedicated facility and proven track record ensure accurate and transparent results for up to 360,000 samples annually. Equipped with 14 Sciex LC/MS/MS instruments, Thermo Exploris Orbitrap HRMS, Shimadzu HPLCs, MSD ECL S 600, and MDL SpectraMax M5 spectrophotometers, we efficiently measure nucleic acids and protein concentration and purity in clinical samples.